Request for Covid-19 Impact Assessment of this Report
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Cord Blood Stem Cells in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Cord Blood Stem Cells market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
3Dmatrix
Aldagen
Angioblast Systems
Athersys
Beike Biotechnology
Biotime
Brainstorm Cell Therapeutics
Caladrius Biosciences
Capricor
Cellerant Therapeutics
Gamida Cell
Globalstem
Hybrid Organ
Intellicell Biosciences
International Stem Cell
Juventas Therapeutics
Mesoblast
Neuralstem
Neurogeneration
Ocata
Osiris Therapeutics
Primegen Biotech
Reneuron Group
Rhinocyte
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Allogeneic Stem Cell
Autologous Stem Cell
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Cord Blood Stem Cells for each application, including
Autoimmune Diseases
Immunodeficiencies
Malignancies,Caners
Solid Tumors
Others
Global Cord Blood Stem Cells Market Research Report 2017
1 Cord Blood Stem Cells Market Overview
1.1 Product Overview and Scope of Cord Blood Stem Cells
1.2 Cord Blood Stem Cells Segment by Type (Product Category)
1.2.1 Global Cord Blood Stem Cells Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
1.2.2 Global Cord Blood Stem Cells Production Market Share by Type (Product Category) in 2016
1.2.3 Allogeneic Stem Cell
1.2.4 Autologous Stem Cell
1.3 Global Cord Blood Stem Cells Segment by Application
1.3.1 Cord Blood Stem Cells Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Autoimmune Diseases
1.3.3 Immunodeficiencies
1.3.4 Malignancies,Caners
1.3.5 Solid Tumors
1.3.6 Others
1.4 Global Cord Blood Stem Cells Market by Region (2012-2022)
1.4.1 Global Cord Blood Stem Cells Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Cord Blood Stem Cells (2012-2022)
1.5.1 Global Cord Blood Stem Cells Revenue Status and Outlook (2012-2022)
1.5.2 Global Cord Blood Stem Cells Capacity, Production Status and Outlook (2012-2022)
2 Global Cord Blood Stem Cells Market Competition by Manufacturers
2.1 Global Cord Blood Stem Cells Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Cord Blood Stem Cells Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Cord Blood Stem Cells Production and Share by Manufacturers (2012-2017)
2.2 Global Cord Blood Stem Cells Revenue and Share by Manufacturers (2012-2017)
2.3 Global Cord Blood Stem Cells Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Cord Blood Stem Cells Manufacturing Base Distribution, Sales Area and Product Type
2.5 Cord Blood Stem Cells Market Competitive Situation and Trends
2.5.1 Cord Blood Stem Cells Market Concentration Rate
2.5.2 Cord Blood Stem Cells Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Cord Blood Stem Cells Capacity, Production, Revenue (Value) by Region (2012-2017)
3.1 Global Cord Blood Stem Cells Capacity and Market Share by Region (2012-2017)
3.2 Global Cord Blood Stem Cells Production and Market Share by Region (2012-2017)
3.3 Global Cord Blood Stem Cells Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Cord Blood Stem Cells Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Cord Blood Stem Cells Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Cord Blood Stem Cells Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Cord Blood Stem Cells Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Cord Blood Stem Cells Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Cord Blood Stem Cells Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Cord Blood Stem Cells Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
4 Global Cord Blood Stem Cells Supply (Production), Consumption, Export, Import by Region (2012-2017)
4.1 Global Cord Blood Stem Cells Consumption by Region (2012-2017)
4.2 North America Cord Blood Stem Cells Production, Consumption, Export, Import (2012-2017)
4.3 Europe Cord Blood Stem Cells Production, Consumption, Export, Import (2012-2017)
4.4 China Cord Blood Stem Cells Production, Consumption, Export, Import (2012-2017)
4.5 Japan Cord Blood Stem Cells Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Cord Blood Stem Cells Production, Consumption, Export, Import (2012-2017)
4.7 India Cord Blood Stem Cells Production, Consumption, Export, Import (2012-2017)
5 Global Cord Blood Stem Cells Production, Revenue (Value), Price Trend by Type
5.1 Global Cord Blood Stem Cells Production and Market Share by Type (2012-2017)
5.2 Global Cord Blood Stem Cells Revenue and Market Share by Type (2012-2017)
5.3 Global Cord Blood Stem Cells Price by Type (2012-2017)
5.4 Global Cord Blood Stem Cells Production Growth by Type (2012-2017)
6 Global Cord Blood Stem Cells Market Analysis by Application
6.1 Global Cord Blood Stem Cells Consumption and Market Share by Application (2012-2017)
6.2 Global Cord Blood Stem Cells Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Cord Blood Stem Cells Manufacturers Profiles/Analysis
7.1 3Dmatrix
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Cord Blood Stem Cells Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 3Dmatrix Cord Blood Stem Cells Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Aldagen
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Cord Blood Stem Cells Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Aldagen Cord Blood Stem Cells Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Angioblast Systems
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Cord Blood Stem Cells Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Angioblast Systems Cord Blood Stem Cells Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 Athersys
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Cord Blood Stem Cells Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Athersys Cord Blood Stem Cells Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 Beike Biotechnology
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Cord Blood Stem Cells Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Beike Biotechnology Cord Blood Stem Cells Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 Biotime
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Cord Blood Stem Cells Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Biotime Cord Blood Stem Cells Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview
7.7 Brainstorm Cell Therapeutics
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Cord Blood Stem Cells Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Brainstorm Cell Therapeutics Cord Blood Stem Cells Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Main Business/Business Overview
7.8 Caladrius Biosciences
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Cord Blood Stem Cells Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Caladrius Biosciences Cord Blood Stem Cells Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Main Business/Business Overview
7.9 Capricor
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Cord Blood Stem Cells Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Capricor Cord Blood Stem Cells Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Main Business/Business Overview
7.10 Cellerant Therapeutics
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Cord Blood Stem Cells Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Cellerant Therapeutics Cord Blood Stem Cells Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.10.4 Main Business/Business Overview
7.11 Gamida Cell
7.12 Globalstem
7.13 Hybrid Organ
7.14 Intellicell Biosciences
7.15 International Stem Cell
7.16 Juventas Therapeutics
7.17 Mesoblast
7.18 Neuralstem
7.19 Neurogeneration
7.20 Ocata
7.21 Osiris Therapeutics
7.22 Primegen Biotech
7.23 Reneuron Group
7.24 Rhinocyte
8 Cord Blood Stem Cells Manufacturing Cost Analysis
8.1 Cord Blood Stem Cells Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Cord Blood Stem Cells
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Cord Blood Stem Cells Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Cord Blood Stem Cells Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Cord Blood Stem Cells Market Forecast (2017-2022)
12.1 Global Cord Blood Stem Cells Capacity, Production, Revenue Forecast (2017-2022)
12.1.1 Global Cord Blood Stem Cells Capacity, Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Cord Blood Stem Cells Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Cord Blood Stem Cells Price and Trend Forecast (2017-2022)
12.2 Global Cord Blood Stem Cells Production, Consumption , Import and Export Forecast by Region (2017-2022)
12.2.1 North America Cord Blood Stem Cells Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Cord Blood Stem Cells Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Cord Blood Stem Cells Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Cord Blood Stem Cells Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Cord Blood Stem Cells Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Cord Blood Stem Cells Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Cord Blood Stem Cells Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Cord Blood Stem Cells Consumption Forecast by Application (2017-2022)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...